(c) 2024 PillSync.com

atorvastatin calcium tablet

1 INDICATIONS AND USAGE Atorvastatin calcium is indicated: To reduce the risk of. Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD. MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD. Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD. As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia. Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia. Hypertriglyceridemia. Atorvastatin calcium is an HMG-CoA reductase inhibitor (statin) indicated ( 1 ): To reduce the risk of о Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD о MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD о Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD. As an adjunct to diet to reduce low-density lipoprotein (LDL-C) in: о Adults with primary hyperlipidemia о Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia. As an adjunct to diet for the treatment of adults with: о Primary dysbetaliproteinemia о Hypertriglyceridemia

lupin pharmaceuticals, inc.


3 years ago OVAL WHITE LU A18 atorvastatin calcium tablet

OVAL WHITE LU A18

3 years ago OVAL WHITE LU A18 atorvastatin calcium tablet

LU A18 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 10 mg tablets (10 mg of atorvastatin): white to off white, elliptical, film coated tablets debossed with "LU" on one side and "A16" on the other side. NDC 68180-635-06 bottles of 30 NDC 68180-635-09 bottles of 90 NDC 68180-635-02 bottles of 500 20 mg tablets (20 mg of atorvastatin): white to off white, elliptical, film coated tablets debossed with "LU" on one side and "A17" on the other side. NDC 68180-636-06 bottles of 30 NDC 68180-636-09 bottles of 90 NDC 68180-636-02 bottles of 500 40 mg tablets (40 mg of atorvastatin): white to off white, elliptical, film coated tablets debossed with "LU" on one side and "A18" on the other side. NDC 68180-637-06 bottles of 30 NDC 68180-637-09 bottles of 90 NDC 68180-637-02 bottles of 500 80 mg tablets (80 mg of atorvastatin): white to off white, elliptical, film coated tablets debossed with "LU" on one side and "A19" on the other side. NDC 68180-638-06 bottles of 30 NDC 68180-638-09 bottles of 90 NDC 68180-638-02 bottles of 500 Storage Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]


More pills like OVAL LU A18

Related Pills

atorvastatin calcium 10 mg

lupin pharmaceuticals, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site